Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Tesla’s Lofty Valuation Faces Scrutiny from Famed Short Seller

Felix Baarz by Felix Baarz
December 2, 2025
in Analysis, Automotive & E-Mobility, Market Commentary, Nasdaq
0
Tesla Stock
0
SHARES
18
VIEWS
Share on FacebookShare on Twitter

Michael Burry, the investor who gained fame for his prescient bet against the U.S. housing market in 2008, has turned his analytical focus to Tesla. His assessment is stark, labeling the electric vehicle pioneer as “ridiculously overvalued” with a market capitalization of $1.4 trillion. He further contends that shareholders are being systematically diluted by the company’s compensation practices. This critique raises a pivotal question for the market: can Elon Musk’s vision continue to justify the premium, or are the bears poised to be proven correct?

A Shifting Narrative and Stalling Growth

Burry’s analysis, detailed in a recent Substack newsletter, takes direct aim at the evolving story around Tesla. He observes a pattern where the company’s dominant narrative shifts as competition intensifies. Initially, the focus was entirely on electric vehicles until rivals emerged. The emphasis then moved to autonomous driving technology, again until competitors entered the space. Now, Burry notes, the narrative is centered on robotics and the Optimus humanoid robot, anticipating the same competitive dynamic.

This shift in focus coincides with a notable deceleration in Tesla’s core business. Vehicle delivery growth stalled in 2024 and reversed into a decline for 2025, prompting increased attention on future projects like the Cybercab robotaxi.

The Dilution Dilemma and Soaring Valuation

A core component of Burry’s critique is shareholder dilution. He calculates that Tesla dilutes existing shareholders by approximately 3.6% annually through stock-based compensation, with no share buybacks to provide an offset. For context, Amazon’s annual dilution rate is about 1.3%, while even Palantir—a company known for high stock compensation—comes in at 4.6%, only slightly above Tesla’s rate.

Burry explicitly links this trend to Elon Musk’s recently approved compensation package, valued at a trillion dollars, warning that “the dilution will certainly continue.”

The valuation metrics supporting his bearish stance are striking. Tesla currently trades at a price-to-earnings (P/E) ratio of roughly 295. Meanwhile, the company’s earnings are declining for the second consecutive year. For most high-growth tech firms, a P/E over 50 is considered aggressive. Based on current figures, Tesla’s stock would need to fall by around 80%, or its earnings would have to increase sixfold, to reach a P/E of 50.

Should investors sell immediately? Or is it worth buying Tesla?

Regional Challenges and Technical Concerns

The competitive and operational pressures are particularly acute in specific markets. In Europe, Tesla’s challenges are mounting. October deliveries plummeted by 48.5% year-over-year, even as the overall European EV market expanded by 26%. For the full year, Tesla’s European sales are tracking for a decline of approximately 30%. Volkswagen has already overtaken Tesla in the region, selling three times as many vehicles through September.

Further complicating the landscape, new data indicates that European customer willingness to purchase Chinese electric vehicles has increased by 16% over the past twelve months, presenting an additional hurdle for the U.S. automaker.

Adding a technical dimension to the concerns, a European EV repair specialist, Croatia-based EV Clinic, has warned of “catastrophic” failure rates for specific LG batteries used in Model 3 and Model Y vehicles. While Panasonic batteries are estimated to last about 250,000 miles, the Chinese-made LG NCM811 packs are reportedly failing at around 150,000 miles, with cell-level repairs deemed impossible in over 90% of cases.

Divergent Views on Wall Street

Despite Burry’s comprehensive critique, Wall Street analysts remain divided. Mizuho Securities reduced its price target on Tesla from $485 to $475 but maintained its “Outperform” rating. Melius Research goes further, labeling Tesla a “Must Own” stock. Their thesis argues that in the multi-trillion dollar autonomous driving sector, “hundreds of billions of value” will ultimately flow to Tesla.

The fundamental debate for investors is now framed in stark terms: Will the promise of Musk’s long-term vision for robotics and autonomy ultimately eclipse the present-day realities of valuation, dilution, and competitive pressure, or has the legendary short-seller identified another major market mispricing?

Ad

Tesla Stock: Buy or Sell?! New Tesla Analysis from February 7 delivers the answer:

The latest Tesla figures speak for themselves: Urgent action needed for Tesla investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Tesla: Buy or sell? Read more here...

Tags: Tesla
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Next Post
Micron Stock

Micron's Strategic Bet: A Multi-Billion Dollar Push to Dominate AI Memory

Rubrik Stock

Can Rubrik's AI Security Focus Unlock Shareholder Value?

Barrick Mining Stock

Barrick Gold's Strategic Unlocking Plan Ignites Share Rally

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com